Research Progress of Adverse Events Related to PD-1/PD-L1 Inhibitors 
Based Combination Therapy

Research Progress of Adverse Events Related to PD-1/PD-L1 Inhibitors 
Based Combination Therapy

The development of immune checkpoint inhibitors (ICIs) has significantly improved the prognosis of cancer patients, but a large population of patients are still ineffective to ICIs treatment or develop aquired drug resistance. In order to improve the clinical benefits, a number of studies on ICIs ba...

Full description

Bibliographic Details
Main Authors: Xiaoyu GUO, Ti WEN, Xiujuan QU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021-07-01
Series:Chinese Journal of Lung Cancer
Subjects:
tumor
pd-1/pd-l1 inhibitors
combination therapy
adverse events
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.26

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.26

Similar Items